Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-flow oxygen during pulmonary rehabilitation in interstitial lung disease
2024-519541-30-00Phase 3Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxygen in interstitial lung disease (ILD) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Mean SpO2 during training period. Started Nov 2024; status: completed.
02
Drugs
oxygen
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on 2024-519541-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519541-30-00.